10:08 AM EDT, 06/17/2025 (MT Newswires) -- The Trump administration is discussing policies that would make it more difficult and expensive for pharmaceutical companies to advertise directly to patients, Bloomberg reported Tuesday, citing people familiar with the matter.

Banning pharma ads outright may leave the White House vulnerable to lawsuits, leaving the administration to focus on creating legal and financial hurdles to discourage the practice, the report said.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 24.19, Change: -0.21, Percent Change: -0.87